Intrahepatic cholangiocarcinoma arising in chronic advanced liver disease and the cholangiocarcinomatous component of hepatocellular cholangiocarcinoma share common phenotypes and cholangiocarcinogenesis

Histopathology

Volumn 59, Issue 6, 2011, Pages 1090-1099

  Xu, Jing ^a,b   Sasaki, Motoko ^a   Harada, Kenichi ^a   Sato, Yasunori ^a   Ikeda, Hiroko ^a   Kim, Ji Hun ^c   Yu, Eunsil ^b   Nakanuma, Yasuni ^a  

^a KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^b SHANXI MEDICAL UNIVERSITY   (China)

^c University of Ulsan College of Medicine   (South Korea)

Author keywords

Cholangiocarcinoma; Combined hepatocellular cholangiocarcinoma; Hepatic progenitor cell; Liver cirrhosis; NCAM

Indexed keywords

CYTOKERATIN 19; CYTOKERATIN 7; EPITHELIAL CELL ADHESION MOLECULE; EPITHELIAL MEMBRANE ANTIGEN; MUCIN; NERVE CELL ADHESION MOLECULE; STEM CELL FACTOR;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BILE DUCT CARCINOMA; CANCER CELL CULTURE; CARCINOGENESIS; CHRONIC ADVANCED LIVER DISEASE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CHOLANGIOCARCINOMA; CHRONIC DISEASE; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER DISEASES; PHENOTYPE; STEM CELLS;

EID: 84862958153     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.04058.x     Document Type: Article

References (29)

1. Nakanuma Y, Sasaki M, Ikeda H et al. Pathology of peripheral intrahepatic cholangiocarcinoma with reference to tumorigenesis. Hepatol. Res. 2008; 38; 325-334.
2. Nakanuma Y, Harada K, Ishikawa A, Zen Y, Sasaki M. Anatomic and molecular pathology of intrahepatic cholangiocarcinoma. J. Hepatobiliary Pancreat. Surg. 2003; 10; 265-281.
3. Malhi H, Gores GJ. Cholangiocarcinoma: modern advances in understanding a deadly old disease. J. Hepatol. 2006; 45; 856-867.
4. Reddy SB, Patel T. Current approaches to the diagnosis and treatment of cholangiocarcinoma. Curr. Gastroenterol. Rep. 2006; 8; 30-37.
5. Ikai I, Arii S, Ichida T et al. Report of the 16th follow-up survey of primary liver cancer. Hepatol. Res. 2005; 32; 163-172.
6. Kubo S, Uenishi T, Yamamoto S et al. Clinicopathologic characteristics of small intrahepatic cholangiocarcinomas of mass-forming type. Hepatol. Res. 2004; 29; 223-227.
7. Roskams TA, Theise ND, Balabaud C et al. Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers. Hepatology 2004; 39; 1739-1745.
8. Roskams T. Progenitor cell involvement in cirrhotic human liver diseases: from controversy to consensus. J. Hepatol. 2003; 39; 431-434.
9. Roskams TA, Libbrecht L, Desmet VJ. Progenitor cells in diseased human liver. Semin. Liver Dis. 2003; 23; 385-396.
10. Crosby HA, Kelly DA, Strain AJ. Human hepatic stem-like cells isolated using c-kit or CD34 can differentiate into biliary epithelium. Gastroenterology 2001; 120; 534-544.
11. Crosby HA, Nijjar SS, de Goyet Jde V, Kelly DA, Strain AJ. Progenitor cells of the biliary epithelial cell lineage. Semin. Cell Dev. Biol. 2002; 13; 397-403.
12. Zhang F, Chen XP, Zhang W et al. Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence. Histopathology 2008; 52; 224-232.
13. Saito K, Minato H, Kono N et al. Establishment of the human cholangiocellular carcinoma cell line (CCKS1). Kanzo 1993; 34; 122-129.
14. Sugawara H, Yasoshima M, Katayanagi K et al. Relationship between interleukin-6 and proliferation and differentiation in cholangiocarcinoma. Histopathology 1998; 3; 145-153.
15. Yamashita T, Ji J, Budhu A et al. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology 2009; 136; 1012-1024.
16. Li WL, Su J, Yao YC et al. Isolation and characterization of bipotent liver progenitor cells from adult mouse. Stem Cells 2006; 24; 322-332.
17. Ishii T, Yasuchika K, Suemori H, Nakatsuji N, Ikai I, Uemoto S. Alpha-fetoprotein producing cells act as cancer progenitor cells in human cholangiocarcinoma. Cancer Lett. 2010; 294; 25-34.
18. de Boer CJ, van Krieken JH, Janssen-van Rhijn CM, Litvinov SV. Expression of Ep-CAM in normal, regenerating, metaplastic, and neoplastic liver. J. Pathol. 1999; 188; 201-206.
19. Roskams T. Liver stem cells and their implication in hepatocellular and cholangiocarcinoma. Oncogene 2006; 25; 3818-3822.
20. Theise ND, Saxena R, Portmann BC et al. The canals of Hering and hepatic stem cells in humans. Hepatology 1999; 30; 1425-1433.
21. Libbrecht L. Hepatic progenitor cells in human liver tumor development. World J. Gastroenterol. 2006; 12; 6261-6265.
22. Libbrecht L, De Vos R, Cassiman D, Desmet V, Aerts R, Roskams T. Hepatic progenitor cells in hepatocellular adenomas. Am. J. Surg. Pathol. 2001; 25; 1388-1396.
23. Kozaka K, Sasaki M, Fujii T et al. A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: 'bile ductular carcinoma'. Histopathology 2007; 51; 390-400.
24. Kim H, Park C, Han KH et al. Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype. J. Hepatol. 2004; 40; 298-304.
25. Baumann U, Crosby HA, Ramani P, Kelly DA, Strain AJ. Expression of the stem cell factor receptor c-kit in normal and diseased pediatric liver: identification of a human hepatic progenitor cell? Hepatology 1999; 30; 112-117.
26. Zaret KS. Regulatory phases of early liver development: paradigms of organogenesis. Nat. Rev. Genet. 2002; 3; 499-512.
27. Shafritz DA, Oertel M, Menthena A, Nierhoff D, Dabeva MD. Liver stem cells and prospects for liver reconstitution by transplanted cells. Hepatology 2006; 43; S89-S98.
28. Schmelzer E, Wauthier E, Reid LM. The phenotype of pluripotent human hepatic progenitors. Stem Cells 2006; 24; 1852-1858.
29. Sasaki M, Tsuneyama K, Ishikawa A, Nakanuma Y. Intrahepatic cholangiocarcinoma in cirrhosis presents granulocyte and granulocyte-macrophage colony-stimulating factor. Hum. Pathol. 2003; 34; 1337-1344.